Improves insulin resistance in older individuals As people age, they produce less glutathione
In addition, cardiovascular outcome trials (CVOTs) have established that, while insulin can be considered safe with regards to major adverse cardiovascular events (MACE) [5, 6], GLP-1RA (liraglutide, semaglutide, dulaglutide, albiglutide, and efpeglenatide) reduce the rates of MACE compared to placebo [7,8,9]
Together, these observations indicated that GLP-1 may have protective effects on beta cells, and raised hopes for long lasting and perhaps disease modifying effects of GLP-1 in diabetes therapy
When should I seek urgent medical advice for skin reactions on Saxenda
Get in touch or browse properties below
A: Technically yes, but it is not recommended